Dr Reddy’s Laboratories sees generic Revlimid, other launches to keep US business firing
Dr Reddy's Laboratories said it expects the generic version of the immunomodulatory drug Revlimid to make meaningful contributions for the ...
Read more
Tag: EBITDA
Recent News
B2B Market Media emerges as your trusted partner for forging connections and fueling breakthroughs. Our mission is simple: to bridge the gap among industry leaders, innovators and decision-makers across sectors like Banks, Education, Urban Cooperative Banks, NBFCs & MFIs, and Insurance Companies.